Abstract:Peptide (Gly-Pro-Leu-Gly-Ile-Ala-Gly-Gln), which can be specifically degraded by matrix metalloproteinases 2 (MMP-2), was conjugated into polylactic acid (PLA), constructing therefore a new type of MMP-responsive drug delivery system (DDS). Microparticles with core-shell structure were fabricated using coaxial electrospray. PEG was used as the shell and PLA-b-peptide-b-PLA as the core material. The water-soluble PEG shell was quickly removed from aqueous environment and the size of the microspheres was reduced from micron to nanometer scale. Eventually, MMP-2 responsive nanoparticles with a diameter of about 100 nm were obtained through coaxial electrospray-template removal method. MMP-2 response of the nanoparticles was investigated by the change of particle size and morphology with DLS and TEM. After coculturing with MMP-2 protease, the spherical skeleton of the nanoparticles was partly degraded. Meanwhile, part of the degraded particles got aggregated. This is because MMP-2 protease specifically cleave the peptide, resulting in the partly disassembly of the nanoparticles and random reassembling of PLA. Doxorubicin (DOX) was used as a model chemotherapeutic drug and loaded in the core of the nanoparticles. The drug loading content and entrapment efficiency of DOX were 0.326% and 75.3%, respectively. The in vitro release profile of DOX from the electrosprayed particles was studied. It was found that the encapsulated DOX was released from the nanoparticles, and the release was controlled by the stimulus of overexpressed MMP-2 protease, and the process lasted more than 20 days. The results show that coaxial electrospray-template removal method did not affect the matrix metalloproteinases response of the peptide, and thus the nanoparticles prepared have good MMP-2 responsiveness. Meanwhile, the size of the particles can be modulated by the coaxial electrospray-template removal method, and the nano-sized particles can be simply and effectively achieved. The study suggests that the coaxial electrospray-template removal method is a promising route to the preparation of stimuli-responsive drug delivery system.

Gelatin-mesoporous silica nanoparticles as matrix metalloproteinases- degradable drug delivery systems in vivo

Matrix Metalloproteinase-Sensitive Size-Shrinkable Nanoparticles for Deep Tumor Penetration and Ph Triggered Doxorubicin Release.

Stimuli-responsive Functionalized Mesoporous Silica Nanoparticles for Drug Release in Response to Various Biological Stimuli

Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release

Enhanced Drug Delivery by Nanoscale Integration of a Nitric Oxide Donor To Induce Tumor Collagen Depletion

Fabrication of MMP-2 Rresponsive Nanoparticles by Coaxial Electrospray-template Removal

Doxorubicin Hydrochloride-Loaded Mesoporous Silica Nanoparticles Inhibit Non-Small Cell Lung Cancer Metastasis by Suppressing VEGF-Mediated Angiogenesis

Mesoporous silica nanoparticle-based intelligent drug delivery system for bienzyme-responsive tumour targeting and controlled release

Optimization and mechanisms of proteolytic enzyme immobilization onto large-pore mesoporous silica nanoparticles: Enhanced tumor penetration

In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.

Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery

Targeted Doxorubicin Delivery to Liver Cancer Cells by PEGylated Mesoporous Silica Nanoparticles with a Ph-Dependent Release Profile

pH-Responsive and Biodegradable ZnO-Capped Mesoporous Silica Composite Nanoparticles for Drug Delivery

Ph-Sensitive Poly(glutamic Acid) Grafted Mesoporous Silica Nanoparticles for Drug Delivery

MMPs-responsive silk spheres for controlled drug release within tumor microenvironment

Bone-Targeted Mesoporous Silica Nanocarrier Anchored by Zoledronate for Cancer Bone Metastasis

Walnut kernel-like mesoporous silica nanoparticles as effective drug carrier for cancer therapy in vitro

Ph-Sensitive Carboxymethyl Chitosan Hydrogels Via Acid-Labile Ortho Ester Linkage As an Implantable Drug Delivery System

A Surface-Grafted Ligand Functionalization Strategy for Coordinate Binding of Doxorubicin at Surface of PEGylated Mesoporous Silica Nanoparticles: Toward Ph-Responsive Drug Delivery

Preparation and Characterization of a Ph-Responsive Mesoporous Silica Nanoparticle Dual-Modified with Biopolymers

Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy